Telmivas 20 mg (Tablet)
Unit Price: ৳ 10.50 (2 x 10: ৳ 210.00)
Strip Price: ৳ 105.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Telmisartan |
| Company | Popular pharmaceuticals ltd |
| Also available as |
Title
- Telmivas Tablets
Categories
- Medicine
- Pharmaceuticals
Description
- Treatment of essential hypertension in adults
- Reduction of cardiovascular morbidity in adults with atherothrombotic cardiovascular disease or type 2 diabetes mellitus with documented target organ damage
- Non-peptide angiotensin-ll receptor antagonist
- Dosage must be individualized
- Blood pressure response is dose-related
- Maximum reduction of blood pressure is generally attained after 4 weeks
- Usual starting dose is 40 mg once a day
- Pediatric use is not established
- No initial dosage adjustment necessary for elderly patients or patients with renal impairment
- Avoid co-administration with aliskiren in patients with diabetes
- Known hypersensitivity to the product or any of its components is a contraindication
- Side effects may include sinus pain, congestion, back pain, diarrhea, intermittent claudication, and skin ulcer
- Pregnancy Category C (first trimester) and D (second and third trimester)
- Avoid fetal or neonatal exposure
- Monitor carefully in patients with impaired hepatic or renal function
- Do not store above 30°C
- Protect from light and high humidity
- Keep out of the reach of children
Dimensions
Color Options
Functions
- Treatment of essential hypertension
- Reduction of cardiovascular morbidity
Materials
Technical Specifications
- Starting dose: 40 mg once a day
- Blood pressure response is dose-related
- Maximum reduction of blood pressure is generally attained after 4 weeks
Design Elements
Usability Features
- Individualized dosage
- No initial dosage adjustment necessary for elderly patients or patients with renal impairment
Storage
- Do not store above 30°C
- Protect from light and high humidity
- Keep out of the reach of children
Additional Features
Safety Features
- Pediatric use is not established
- Known hypersensitivity is a contraindication
Precautions
- Avoid fetal or neonatal exposure
- Monitor carefully in patients with impaired hepatic or renal function
Warnings
- Avoid co-administration with aliskiren in patients with diabetes
Side Effects
- Sinus pain
- Congestion
- Back pain
- Diarrhea
- Intermittent claudication
- Skin ulcer
Drug Class
- Angiotensin-ll receptor blocker
Overdose Effects
- Hypotension
- Dizziness
- Tachycardia
- Increase in serum creatinine
- Acute renal failure
Interaction
- Increased risk of renal impairment and loss of antihypertensive effect with NSAIDs
- Avoid co-administration with aliskiren in patients with diabetes
Mode of Action
- Non-peptide angiotensin-ll receptor antagonist
Dosage & Administration
- Dosage must be individualized
- No initial dosage adjustment necessary for elderly patients or patients with renal impairment
- Pediatric use is not established
Indications
- Treatment of essential hypertension in adults
- Reduction of cardiovascular morbidity in adults with atherothrombotic cardiovascular disease or type 2 diabetes mellitus with documented target organ damage
Contraindications
- Known hypersensitivity to the product or any of its components
Pregnancy & Lactation
- Pregnancy Category C (first trimester) and D (second and third trimester)
- Avoid fetal or neonatal exposure
Geriatric Use
- No overall differences in effectiveness and safety observed in geriatric patients
Hepatic Impairment
- Monitor carefully and up titrate slowly in patients with biliary obstructive disorders or hepatic insufficiency